AAAAAA

   
Results: 1-8 |
Results: 8
The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-alpha]-pyrimidine: A corticotropin-releasing factor (hCRF(1)) antagonist
Authors: Gilligan, PJ Baldauf, C Cocuzza, A Chidester, D Zaczek, R Fitzgerald, LW McElroy, J Smith, MA Shen, HSL Saye, JA Christ, D Trainor, G Robertson, DW Hartig, P
Citation: Pj. Gilligan et al., The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-alpha]-pyrimidine: A corticotropin-releasing factor (hCRF(1)) antagonist, BIO MED CH, 8(1), 2000, pp. 181-189
Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine
Authors: Fitzgerald, LW Burn, TC Brown, BS Patterson, JP Corjay, MH Valentine, PA Sun, JH Link, JR Abbaszade, I Hollis, JM Largent, BL Hartig, PR Hollis, GF Meunier, PC Robichaud, AJ Robertson, DW
Citation: Lw. Fitzgerald et al., Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine, MOLEC PHARM, 57(1), 2000, pp. 75-81
4-(1,3-dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)-pyrazolo[1,5-a]-1,3,5-triazine: A portent, orally bioavailable CRF1 receptor antagonist
Authors: He, LQ Gilligan, PJ Zaczek, R Fitzgerald, LW McElroy, J Shen, HSL Saye, JA Kalin, NH Shelton, S Christ, D Trainor, G Hartig, P
Citation: Lq. He et al., 4-(1,3-dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)-pyrazolo[1,5-a]-1,3,5-triazine: A portent, orally bioavailable CRF1 receptor antagonist, J MED CHEM, 43(3), 2000, pp. 449-456
Thiazolo[4,5-d]pyrimidine thiones and -ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists
Authors: Beck, JP Curry, MA Chorvat, RJ Fitzgerald, LW Gilligan, PJ Zaczek, R Trainor, GL
Citation: Jp. Beck et al., Thiazolo[4,5-d]pyrimidine thiones and -ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists, BIOORG MED, 9(8), 1999, pp. 1185-1188
Purin-8-ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists
Authors: Beck, JP Arvanitis, AG Curry, MA Rescinito, JT Fitzgerald, LW Gilligan, PJ Zaczek, R Trainor, GL
Citation: Jp. Beck et al., Purin-8-ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists, BIOORG MED, 9(7), 1999, pp. 967-972
Messenger RNA editing of the human serotonin 5-HT2C receptor
Authors: Fitzgerald, LW Iyer, G Conklin, DS Krause, CM Marshall, A Patterson, JP Tran, DP Jonak, GJ Hartig, PR
Citation: Lw. Fitzgerald et al., Messenger RNA editing of the human serotonin 5-HT2C receptor, NEUROPSYCH, 21(2), 1999, pp. S82-S90
High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: Evidence favoring theternary complex and two-state models of agonist action
Authors: Fitzgerald, LW Conklin, DS Krause, CM Marshall, AP Patterson, JP Tran, DP Iyer, G Kostich, WA Largent, BL Hartig, PR
Citation: Lw. Fitzgerald et al., High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: Evidence favoring theternary complex and two-state models of agonist action, J NEUROCHEM, 72(5), 1999, pp. 2127-2134
Synthesis, corticotropin-releasing factor receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and -pyridines
Authors: Chorvat, RJ Bakthavatchalam, R Beck, JP Gilligan, PJ Wilde, RG Cocuzza, AJ Hobbs, FW Cheeseman, RS Curry, M Rescinito, JP Krenitsky, P Chidester, D Yarem, JA Klaczkiewicz, JD Hodge, CN Aldrich, PE Wasserman, ZR Fernandez, CH Zaczek, R Fitzgerald, LW Huang, SM Shen, HL Wong, YN Chien, BM Quon, CY Arvanitis, A
Citation: Rj. Chorvat et al., Synthesis, corticotropin-releasing factor receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and -pyridines, J MED CHEM, 42(5), 1999, pp. 833-848
Risultati: 1-8 |